POSEIDA THERAPEUTICS INC (PSTX) Stock Cash Flow
NASDAQ:PSTX - Nasdaq - US73730P1084 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -60.76M | -123.43M | -64.00M | -124.97M | -129.78M | |||
| Depreciation Amortization | 5.48M | 5.61M | 5.17M | 4.55M | 2.59M | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | 23.85M | 14.08M | 13.72M | 20.17M | 5.62M | |||
| Interest Paid | 8.09M | 7.80M | 5.14M | 2.72M | 3.03M | |||
| Other non cash items | 16.40M | 11.57M | 18.34M | -2.29M | 8.24M | |||
| OPERATING CASH FLOW | -15.03M | -92.17M | -26.77M | -102.54M | -113.33M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -2.10M | -3.07M | -3.92M | -2.63M | -16.91M | |||
| Other Investing Activity | 40.26M | 42.20M | -199.41M | 225.02M | -187.52M | |||
| INVESTING CASH FLOW | 38.16M | 39.13M | -203.33M | 222.38M | -204.43M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 30.00M | N/A | 0.00 | |||
| Stock Issued/Repurchased | 1.29M | 16.62M | 76.61M | 2.52M | 310.11M | |||
| Other Financing Activity | -596.00K | -494.00K | -1.45M | 0.00 | 3.83M | |||
| FINANCING CASH FLOW | 696.00K | 16.13M | 105.16M | 2.52M | 313.94M | |||
| CHANGE IN CASH | 23.83M | -36.91M | -124.94M | 122.36M | -3.82M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -15.03M | -92.17M | -26.77M | -102.54M | -113.33M | |||
| Capital Expenditure | -2.10M | -3.07M | -3.92M | -2.63M | -16.91M | |||
| FREE CASH FLOW | -17.13M | -95.23M | -30.69M | -105.17M | -130.24M | |||
All data in USD